Nabla

Ambient AI documentation company whose assistant transcribes clinician and patient conversations and drafts structured clinical notes for clinician review.

nabla.com

At a glance

Headquarters: Paris, France
Business model: B2B
Stage: Series C
Products profiled: 2
Operating markets: France, United States
Sources cited: 7
In the library since: 24 September 2026

What it does

Nabla's assistant listens to the conversation between a clinician and a patient and drafts structured clinical notes for the clinician to review. The company also offers dictation and coding products, which it says are built into Epic and other electronic health records.

The company describes two hubs, an office in Paris and an office in Brooklyn, New York. STAT (21 July 2026) calls it Paris based and reports that all of its revenue currently comes from the United States.

What the company says

The company’s own statements, attributed to it and not presented as established fact.

Nabla says it works with more than 130 health organisations and more than 85,000 clinicians, supports more than 20 million patient encounters a year, and saves clinicians more than an hour a day on documentation. In June 2025 it announced a $70 million round that it calls a Series C, bringing total funding to $120 million; STAT describes the same round as a Series B.

In July 2026 Brian Manning became chief executive and co-founder Alexandre Lebrun became executive chairman and chief AI officer.

The App Store lists the seller as Nabla Technologies. The legal form and the founding year are not recorded because no primary source for them has been read.